vs
Side-by-side financial comparison of Fold Holdings, Inc. (FLD) and Taysha Gene Therapies, Inc. (TSHA). Click either name above to swap in a different company.
Fold Holdings, Inc. is the larger business by last-quarter revenue ($9.1M vs $5.5M, roughly 1.7× Taysha Gene Therapies, Inc.). Fold Holdings, Inc. runs the higher net margin — -379.9% vs -507.8%, a 127.8% gap on every dollar of revenue. On growth, Taysha Gene Therapies, Inc. posted the faster year-over-year revenue change (171.3% vs 8.2%). Over the past eight quarters, Fold Holdings, Inc.'s revenue compounded faster (36.1% CAGR vs 26.8%).
Fold Holdings, Inc. is a U.S.-based fintech firm specializing in crypto-integrated consumer financial products. Its core offerings include a rewards debit card that provides Bitcoin and other cryptocurrency cashback on routine purchases, alongside user-friendly digital wallet tools for secure crypto storage, serving primarily the North American consumer market.
Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company specializing in developing adeno-associated virus (AAV)-based gene therapies for rare monogenic central nervous system disorders with high unmet medical needs. Its core pipeline targets serious life-threatening neurological conditions, with primary operations and market focus across North America and European regions.
FLD vs TSHA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.1M | $5.5M |
| Net Profit | $-34.7M | $-27.9M |
| Gross Margin | — | — |
| Operating Margin | -380.0% | -516.0% |
| Net Margin | -379.9% | -507.8% |
| Revenue YoY | 8.2% | 171.3% |
| Net Profit YoY | -7232.4% | -48.3% |
| EPS (diluted) | $-0.02 | $-0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.1M | $5.5M | ||
| Q3 25 | $7.4M | $0 | ||
| Q2 25 | $8.2M | $2.0M | ||
| Q1 25 | $7.1M | $2.3M | ||
| Q4 24 | $8.4M | $2.0M | ||
| Q3 24 | $5.2M | $1.8M | ||
| Q2 24 | $5.1M | $1.1M | ||
| Q1 24 | $4.9M | $3.4M |
| Q4 25 | $-34.7M | $-27.9M | ||
| Q3 25 | $554.2K | $-32.7M | ||
| Q2 25 | $13.4M | $-26.9M | ||
| Q1 25 | $-48.9M | $-21.5M | ||
| Q4 24 | $486.4K | $-18.8M | ||
| Q3 24 | $-62.3M | $-25.5M | ||
| Q2 24 | $-2.3M | $-20.9M | ||
| Q1 24 | $-945.0K | $-24.1M |
| Q4 25 | -380.0% | -516.0% | ||
| Q3 25 | 7.5% | — | ||
| Q2 25 | — | -1347.1% | ||
| Q1 25 | -689.6% | -930.5% | ||
| Q4 24 | -9.1% | -985.8% | ||
| Q3 24 | -15.3% | -1448.4% | ||
| Q2 24 | -12.2% | -1915.4% | ||
| Q1 24 | -14.7% | -713.3% |
| Q4 25 | -379.9% | -507.8% | ||
| Q3 25 | 7.5% | — | ||
| Q2 25 | 164.2% | -1353.6% | ||
| Q1 25 | -689.6% | -935.2% | ||
| Q4 24 | 5.8% | -929.0% | ||
| Q3 24 | -1188.7% | -1427.5% | ||
| Q2 24 | -45.1% | -1882.0% | ||
| Q1 24 | -19.2% | -705.4% |
| Q4 25 | $-0.02 | $-0.08 | ||
| Q3 25 | $0.01 | $-0.09 | ||
| Q2 25 | $0.28 | $-0.09 | ||
| Q1 25 | $-1.92 | $-0.08 | ||
| Q4 24 | $0.09 | $-0.07 | ||
| Q3 24 | $-10.68 | $-0.10 | ||
| Q2 24 | $-0.40 | $-0.09 | ||
| Q1 24 | $-0.16 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.7M | $319.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $63.0M | $246.9M |
| Total Assets | $153.5M | $343.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.7M | $319.8M | ||
| Q3 25 | $6.7M | $297.3M | ||
| Q2 25 | $6.6M | $312.8M | ||
| Q1 25 | $11.7M | $116.6M | ||
| Q4 24 | $18.3M | $139.0M | ||
| Q3 24 | — | $157.7M | ||
| Q2 24 | — | $172.7M | ||
| Q1 24 | — | $124.0M |
| Q4 25 | $63.0M | $246.9M | ||
| Q3 25 | $94.7M | $219.0M | ||
| Q2 25 | $88.5M | $248.7M | ||
| Q1 25 | $71.9M | $55.1M | ||
| Q4 24 | $-67.8M | $71.5M | ||
| Q3 24 | $-7.4M | $88.8M | ||
| Q2 24 | $-74.0M | $108.9M | ||
| Q1 24 | $-9.4M | $53.8M |
| Q4 25 | $153.5M | $343.3M | ||
| Q3 25 | $191.0M | $316.6M | ||
| Q2 25 | $182.1M | $333.3M | ||
| Q1 25 | $148.5M | $138.4M | ||
| Q4 24 | $125.7M | $160.4M | ||
| Q3 24 | $52.2M | $180.2M | ||
| Q2 24 | $51.8M | $200.4M | ||
| Q1 24 | $51.5M | $153.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-16.1M | $-26.7M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-16.1M | $-26.7M | ||
| Q3 25 | $-2.5M | $-24.2M | ||
| Q2 25 | $-4.0M | $-20.2M | ||
| Q1 25 | $-5.0M | $-22.0M | ||
| Q4 24 | $-3.3M | $-18.3M | ||
| Q3 24 | $-2.2M | $-21.6M | ||
| Q2 24 | $-859.6K | $-21.5M | ||
| Q1 24 | $-354.2K | $-19.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-24.3M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-18.3M | ||
| Q3 24 | — | $-21.6M | ||
| Q2 24 | — | $-21.7M | ||
| Q1 24 | — | $-19.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -905.5% | ||
| Q3 24 | — | -1210.9% | ||
| Q2 24 | — | -1951.9% | ||
| Q1 24 | — | -584.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 2.0% | ||
| Q2 24 | — | 18.1% | ||
| Q1 24 | — | 4.1% |
| Q4 25 | — | — | ||
| Q3 25 | -4.47× | — | ||
| Q2 25 | -0.30× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -6.82× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FLD
| Banking And Payment Revenues | $8.4M | 92% |
| Other | $706.0K | 8% |
TSHA
Segment breakdown not available.
